FDA declines to approve Corcept's rare disorder drug As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to Corcept by turning down its new Cushing's drug.

As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to #CorceptTherapeutics with a decision not to approve #relacorilant, a drug for a rare #hormonaldisorder that causes #highbloodpressure.

🚨 He Drank Toilet Water Because Of This Brain Cyst

Subscribe to read more on www.pouringpotions.com

#RathkesCleftCyst #PituitaryDisorder #NoThirstControl #Endocrinology #SodiumImbalance #Hyponatremia #ToiletWater #HormonalDisorder #DiabetesInsipidus #BrainCyst #MedicalReels